Frank Takkinen
Stock Analyst at Lake Street
(0.88)
# 3,709
Out of 4,856 analysts
58
Total ratings
27.27%
Success rate
-18.65%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELUT Elutia | Maintains: Buy | $10 → $8 | $1.90 | +321.05% | 3 | May 9, 2025 | |
| SGHT Sight Sciences | Maintains: Hold | $2.5 → $3 | $4.07 | -26.29% | 4 | May 9, 2025 | |
| NOTV Inotiv | Maintains: Buy | $6 → $5 | $3.01 | +66.11% | 7 | May 8, 2025 | |
| CVRX CVRx, Inc. | Maintains: Buy | $19 → $14 | $6.23 | +124.72% | 7 | Apr 8, 2025 | |
| LNSR LENSAR | Downgrades: Hold | $16 → $15 | $13.07 | +14.77% | 2 | Mar 24, 2025 | |
| HYPR Hyperfine | Initiates: Buy | $1.5 | $0.77 | +93.75% | 1 | Mar 24, 2025 | |
| AXGN Axogen | Initiates: Buy | $30 | $10.41 | +188.18% | 1 | Mar 17, 2025 | |
| CLBT Cellebrite DI | Maintains: Buy | $17 → $26 | $16.62 | +56.44% | 3 | Feb 14, 2025 | |
| CLPT ClearPoint Neuro | Maintains: Buy | $17 → $30 | $13.31 | +125.39% | 4 | Jan 21, 2025 | |
| KRMD KORU Medical Systems | Maintains: Buy | $4 → $5 | $3.02 | +65.56% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $5.38 | +272.09% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.44 | +104.92% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $1.86 | +330.11% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $29.19 | +2.77% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $3.40 | +252.94% | 1 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $1.48 | +305.41% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.31 | +73.16% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $12.95 | -7.34% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $305 → $350 | $136.64 | +156.15% | 1 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $5 | $3.93 | +27.39% | 3 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $1.73 | +420.23% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $1.80 | +788.89% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.64 | +1,337.25% | 2 | Jan 18, 2023 |
Elutia
May 9, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $1.90
Upside: +321.05%
Sight Sciences
May 9, 2025
Maintains: Hold
Price Target: $2.5 → $3
Current: $4.07
Upside: -26.29%
Inotiv
May 8, 2025
Maintains: Buy
Price Target: $6 → $5
Current: $3.01
Upside: +66.11%
CVRx, Inc.
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $6.23
Upside: +124.72%
LENSAR
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $13.07
Upside: +14.77%
Hyperfine
Mar 24, 2025
Initiates: Buy
Price Target: $1.5
Current: $0.77
Upside: +93.75%
Axogen
Mar 17, 2025
Initiates: Buy
Price Target: $30
Current: $10.41
Upside: +188.18%
Cellebrite DI
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $16.62
Upside: +56.44%
ClearPoint Neuro
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $13.31
Upside: +125.39%
KORU Medical Systems
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $3.02
Upside: +65.56%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $5.38
Upside: +272.09%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $2.44
Upside: +104.92%
Aug 13, 2024
Maintains: Buy
Price Target: $14 → $8
Current: $1.86
Upside: +330.11%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $29.19
Upside: +2.77%
Jun 4, 2024
Initiates: Buy
Price Target: $12
Current: $3.40
Upside: +252.94%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $1.48
Upside: +305.41%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.31
Upside: +73.16%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $12.95
Upside: -7.34%
Aug 2, 2023
Maintains: Buy
Price Target: $305 → $350
Current: $136.64
Upside: +156.15%
Jul 19, 2023
Maintains: Buy
Price Target: $2.5 → $5
Current: $3.93
Upside: +27.39%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $1.73
Upside: +420.23%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $1.80
Upside: +788.89%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.64
Upside: +1,337.25%